• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Surveillance for hepatocellular carcinoma after hepatitis C virus eradication.

作者信息

Testino Gianni

机构信息

Alcohological Regional Center, Ligurian Region, ASL3, IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy -

出版信息

Minerva Med. 2022 Jun;113(3):569-570. doi: 10.23736/S0026-4806.20.06496-4. Epub 2020 Mar 12.

DOI:10.23736/S0026-4806.20.06496-4
PMID:32166937
Abstract
摘要

相似文献

1
Surveillance for hepatocellular carcinoma after hepatitis C virus eradication.
Minerva Med. 2022 Jun;113(3):569-570. doi: 10.23736/S0026-4806.20.06496-4. Epub 2020 Mar 12.
2
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma.
J Formos Med Assoc. 2021 Apr;120(4):1160. doi: 10.1016/j.jfma.2020.11.012. Epub 2020 Dec 5.
3
Response to letter to the editor "The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma".对致编辑信《直接抗病毒药物清除丙型肝炎病毒后细胞因子变化对肝细胞癌风险的影响》的回复
J Formos Med Assoc. 2021 Apr;120(4):1161-1164. doi: 10.1016/j.jfma.2020.12.016. Epub 2020 Dec 24.
4
[Residual risk of liver disease after hepatitis C virus eradication].丙型肝炎病毒根除后肝病的残余风险
Rev Med Suisse. 2021 Sep 1;17(748):1453-1456.
5
Reply to: 'Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan'.回复：“日本代偿期晚期慢性肝病患者丙型肝炎病毒根除后肝细胞癌的风险分层”
J Hepatol. 2022 Aug;77(2):571-572. doi: 10.1016/j.jhep.2022.04.031. Epub 2022 May 5.
6
Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence.直接作用抗病毒药物对多次复发的丙型肝炎病毒相关复发性肝细胞癌患者的疗效。
J Viral Hepat. 2021 Nov;28(11):1597-1603. doi: 10.1111/jvh.13579. Epub 2021 Sep 6.
7
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.丙型肝炎病毒的清除可延长接受分子靶向药物治疗的肝细胞癌患者的总生存期。
J Gastroenterol. 2022 Feb;57(2):90-98. doi: 10.1007/s00535-021-01837-5. Epub 2022 Jan 15.
8
Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?
J Hepatol. 2020 Aug;73(2):469-470. doi: 10.1016/j.jhep.2020.03.035. Epub 2020 Jun 1.
9
Hepatocellular carcinoma associated with direct-acting antiviral therapy for hepatitis C virus: A report of two cases.
Rev Gastroenterol Mex (Engl Ed). 2021 Apr-Jun;86(2):197-199. doi: 10.1016/j.rgmx.2020.04.008. Epub 2020 Nov 11.
10
Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?对于 HCV 感染后已治愈的肝硬化患者，我们是否应继续对其进行肝细胞癌和胃食管静脉曲张监测？
Eur J Intern Med. 2021 Dec;94:6-14. doi: 10.1016/j.ejim.2021.08.023. Epub 2021 Sep 23.